(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -57.43%22.87M | 34.84%143.65M | 53.72%53.72M | 64.64%106.53M | 41.64%34.95M | 35.08%64.71M | 4.25%24.67M | 7.97%47.9M | -21.26%23.67M | -12.44%44.37M |
Operating income | -57.43%22.87M | 34.84%143.65M | 53.72%53.72M | 64.64%106.53M | 41.64%34.95M | 35.08%64.71M | 4.25%24.67M | 7.97%47.9M | -21.26%23.67M | -12.44%44.37M |
Cost of sales | 45.25%-20.43M | -3.52%-90.81M | 1.88%-37.32M | -28.43%-87.73M | -66.18%-38.04M | -50.27%-68.31M | -20.53%-22.89M | -21.03%-45.46M | 23.57%-18.99M | 4.13%-37.56M |
Operating expenses | 45.25%-20.43M | -3.52%-90.81M | 1.88%-37.32M | -28.43%-87.73M | -66.18%-38.04M | -50.27%-68.31M | -20.53%-22.89M | -21.03%-45.46M | 23.57%-18.99M | 4.13%-37.56M |
Gross profit | -85.15%2.44M | 180.95%52.84M | 631.56%16.4M | 622.59%18.81M | -272.79%-3.09M | -247.02%-3.6M | -61.82%1.79M | -64.05%2.45M | -10.28%4.68M | -40.76%6.81M |
Administrative expenses | 17.37%-6.23M | -14.51%-10.33M | -33.03%-7.54M | -0.16%-9.02M | 32.81%-5.67M | -40.40%-9.01M | -14.95%-8.44M | 52.08%-6.41M | ---7.34M | ---13.39M |
Research and development expenses | ---- | 96.51%-259K | ---- | -826.09%-7.42M | ---- | ---801K | ---- | ---- | ---- | ---- |
Employee expense | 2.81%-14.53M | -17.35%-29.83M | -27.00%-14.95M | -2.36%-25.42M | 0.45%-11.77M | -57.71%-24.83M | -80.81%-11.83M | 24.52%-15.75M | 24.26%-6.54M | 43.92%-20.86M |
Depreciation and amortization | -24.12%-3.56M | 10.65%-7.92M | -8.76%-2.87M | -5.90%-8.86M | -16.52%-2.64M | -78.97%-8.37M | -44.02%-2.26M | -50.52%-4.68M | 1.44%-1.57M | -141.52%-3.11M |
Revaluation surplus | -659.69%-10.91M | 211.90%16.66M | 136.67%1.95M | -644.60%-14.88M | -349.09%-5.32M | 123.35%2.73M | 116.42%2.14M | -155.64%-11.7M | -507.46%-13.01M | 340.87%21.03M |
-Changes in the fair value of derivative financial instruments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -166.86%-11.71M | -669.31%-11.71M | 235.27%17.51M |
-Changes in the fair value of financial assets | -312.56%-4.15M | 225.99%18.75M | 136.67%1.95M | -644.60%-14.88M | -349.09%-5.32M | 91,000.00%2.73M | 264.10%2.14M | 101.69%3K | ---1.3M | ---178K |
-Changes in the fair value of other assets | ---6.77M | ---2.1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -12.16%3.7M |
Impairment and provision | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -600.33%-3M | ---- | 180.00%600K |
-Other impairment is provision | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -600.33%-3M | ---- | 106.15%600K |
Special items of operating profit | -8.58%-2.84M | -88.50%-7.06M | -356.64%-2.61M | -50.30%-3.75M | -134.98%-572K | -130.38%-2.49M | 9.07%1.64M | 1,863.16%8.21M | 68.24%1.5M | -12.37%418K |
Operating profit | -270.54%-35.64M | 127.90%14.1M | 66.90%-9.62M | -9.01%-50.54M | -71.22%-29.05M | -50.12%-46.36M | 23.84%-16.97M | -263.60%-30.88M | -2,288.00%-22.28M | 76.40%-8.49M |
Financing cost | 89.23%-263K | 64.49%-2.97M | 36.96%-2.44M | -18.13%-8.36M | -14.34%-3.87M | 59.72%-7.08M | 75.39%-3.39M | 19.38%-17.57M | -34.36%-13.77M | -54.37%-21.79M |
Earning before tax | -197.69%-35.9M | 118.90%11.13M | 63.38%-12.06M | -10.22%-58.9M | -61.75%-32.93M | -10.29%-53.44M | 43.53%-20.36M | -59.99%-48.45M | -86.69%-36.05M | 68.67%-30.28M |
After-tax profit from continuing operations | -197.69%-35.9M | 118.90%11.13M | 63.38%-12.06M | -10.22%-58.9M | -61.75%-32.93M | -10.29%-53.44M | 43.53%-20.36M | -59.99%-48.45M | -86.69%-36.05M | 68.67%-30.28M |
After-tax profit from non-continuing business | 12.88%13.69M | ---- | --12.12M | ---- | ---- | -100.68%-1.08M | 89.10%-756K | 2,842.76%159.67M | 76.51%-6.93M | 107.52%5.43M |
Earning after tax | -34,272.31%-22.21M | 118.90%11.13M | 100.20%65K | -8.03%-58.9M | -55.96%-32.93M | -149.02%-54.52M | 50.88%-21.11M | 547.43%111.22M | 11.97%-42.98M | 85.27%-24.86M |
Minority shareholders should account for profits from continuing business | -513.95%-528K | ---- | ---86K | ---- | ---- | ---721K | ---463K | ---- | ---- | ---- |
Minority shareholders should account for non-continuing business profits | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 27.86%-21.8M |
Minority profit | -513.95%-528K | 30.92%-1.54M | 90.35%-86K | -209.99%-2.24M | -92.44%-891K | ---721K | ---463K | ---- | ---- | 27.86%-21.8M |
Shareholders should account for profits from continuing business | -195.41%-35.37M | ---- | ---11.97M | ---- | ---- | -8.81%-52.72M | 44.81%-19.89M | -59.99%-48.45M | -86.69%-36.05M | 68.67%-30.28M |
Shareholders should account for profits from non-continuing business | 12.88%13.69M | ---- | --12.12M | ---- | ---- | -100.68%-1.08M | 89.10%-756K | 486.50%159.67M | 58.57%-6.93M | 164.97%27.23M |
Profit attributable to shareholders | -14,460.26%-21.68M | 122.37%12.68M | 100.47%151K | -5.33%-56.66M | -55.14%-32.04M | -148.37%-53.8M | 51.96%-20.65M | 3,735.89%111.22M | -19.25%-42.98M | 97.79%-3.06M |
Basic earnings per share | -10,900.00%-0.0108 | 119.76%0.0066 | 100.53%0.0001 | -5.36%-0.0334 | -56.20%-0.0189 | -129.68%-0.0317 | 86.04%-0.0121 | 1,850.82%0.1068 | -19.26%-0.0867 | 97.94%-0.0061 |
Diluted earnings per share | -10,900.00%-0.0108 | 119.76%0.0066 | 100.53%0.0001 | -5.36%-0.0334 | -56.20%-0.0189 | -129.68%-0.0317 | 86.04%-0.0121 | 1,850.82%0.1068 | -19.26%-0.0867 | 97.94%-0.0061 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- |
Auditor | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited | -- | Furimazer Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data